The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multiplex Genome Engineering Using CRISPR/Cas Systems
Open accessAbstract
Genome Editing: Clustered regularly interspaced short palindromic repeats (CRISPR) function as part of an adaptive immune system in a range of prokaryotes: Invading phage and plasmid DNA is targeted for cleavage by complementary CRISPR RNAs (crRNAs) bound to a CRISPR-associated endonuclease (see the Perspective by van der Oost ). Cong et al. (p. 819 , published online 3 January) and Mali et al. (p. 823 , published online 3 January) adapted this defense system to function as a genome editing tool in eukaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Cong et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 is guided by a 20 nt fraction of the gRNA”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and it maintains cleaving activity even with 3-5 mismatches at the PAM-distal end of the gRNA molecule [59,81,102].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In January 2013, almost simultaneously, five research articles authored by different research teams appeared, all reporting that they had achieved the goal.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Target specificity of the CRISPR/Cas system is very high and a single mutation can disrupt targeting 20”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Cong et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“By introducing an aspartate-to-alanine (D10A) mutation in the RuvC active domain of Cas9, the resulting mutant, Cas9 nickase, (Cas9n) will nick the target DNA, originating single-stranded breaks rather than DSB [54,81].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9n nicks the target DNA, originating single-stranded breaks rather than DSB [54,81].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“by introducing a specific mutation in the RuvC domain of Cas9, a Cas9 nickase variant (Cas9n) is created.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“The markedly high efficiency of CRISPR/Cas systems coupled with the above-mentioned advantages over other methods justify the CRISPR “epidemic” that the scientific community experienced in 2013 [62,81,100,101].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“The pigs were engineered to carry 69 genomic edits, using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9)-mediated nonhomologous end joining and homology-directed repair30,31, and recombinase-mediated cassette exchange32 (Fig. 2a, Extended Data Fig. 1a and Supplementary Table 2).”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [30]
In the citing paper
“When a double-stranded break is introduced into genomic DNA, cells can repair the break by using a DNA molecule with high sequence similarity as a template. If an artificial template is provided while the DNA break is introduced, this pathway provides a mean to incorporate desired DNA sequences into the genome34,35”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [34]
In the citing paper
“The discovery, made less than 10 years ago, that a simple two-component system of a Cas protein (Streptococcus pyogenes Cas9) bound to a single guide RNA (sgRNA) can function as a programmable nuclease33 that can be deployed to cleave specific sequences in mammalian genomes34,35 has been transformative for biomedical research and the development of gene therapies.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [34]
In the citing paper
“The CRISPR/Cas9 system has been used for multiplex genome cleavage.20”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [20]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [20]
In the citing paper
“selection of LTR-A-and -B-directed, 30-bp protospacer and also precrRNA system reflecting the original bacterial immune mechanism to enhance specificity/efficiency vs. 20-bp protospacer-based, chimeric crRNA-tracRNA system”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [16]
In the citing paper
“as mentioned in several recent publications, Cas9 tolerates mismatches between the guide RNA and target DNA in a sequence-dependent manner and potentially tolerates up to five target mismatches in human cells [12], [24], [25], [26], [27], thereby promoting undesired off-target mutations.”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Because the sequence specificity of Streptococcus pyogenes Cas9 tolerates 4 mismatches between the gRNA and complementary sequence”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Compared with well-known, site-specific genome editing technologies, such as ZFNs and TALENs, the new CRISPR-Cas approach is more convenient and efficient [10], [12].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“non-specific cleavage may occur in the cellular genome [12], [24], [25], [26], [27].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 is a naturally occurring bacterial immune system that uses a novel nuclease system to protect bacteria from phage infection (6-9), and it has recently been harnessed for a variety of genome-engineering applications (10)(11)(12)(13)(14)(15)(16)(17).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [11]
In the citing paper
“In the few available publications using CRISPR/Cas9 system, the gene editing frequency is comparable with ZFN or TALEN [87].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“As described by Zhang group [87], CRISPR/Cas 9 system can be easily employed to target multiple sites to induce a deletion of a large gene fragment.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“Moreover, no significant cytotoxicity was observed [87,88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“while in December 2012 Zhang and the Broad Institute also submitted a patent application [43] simultaneously with the acceptance of Zhang’s paper on human cells’ editing for publication in Science [35].”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,598
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009) · Science · doi:10.1126/science.1178811 · Cited by 2,470
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,336
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,214
Application of CRISPR/Cas9 in Crop Quality Improvement
Liu, Q., Yang, F., Zhang, J., Liu, H., Rahman, S., Islam, S., Ma, W., & She, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084206 · Cited by 239
A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
Tajan, M., Hock, A. K., Blagih, J., Robertson, N. A., Labuschagne, C. F., Kruiswijk, F., Humpton, T. J., Adams, P. D., & Vousden, K. H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.005 · Cited by 230
Efficient gene editing in Neurospora crassa with CRISPR technology
Matsuura, T., Baek, M. L., Kwon, J., & Hong, C. I. (2015) · Fungal Biology and Biotechnology · doi:10.1186/s40694-015-0015-1 · Cited by 235
The New State of the Art: Cas9 for Gene Activation and Repression
Russa, M. F. L., & Qi, L. S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-15 · Cited by 241
Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish
Hisano, Y., Sakuma, T., Nakade, S., Ohga, R., Ota, S., Okamoto, H., Yamamoto, T., & Kawahara, A. (2015) · Scientific Reports · doi:10.1038/srep08841 · Cited by 239
Gene targeting using the Agrobacterium tumefaciens-mediated CRISPR-Cas system in rice
Xu, R., Li, H., Qin, R., Wang, L., Li, L., Wei, P., & Yang, J. (2014) · Rice · doi:10.1186/s12284-014-0005-6 · Cited by 232
Use of designer nucleases for targeted gene and genome editing in plants
Weeks, D. P., Spalding, M. H., & Yang, B. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12448 · Cited by 231
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia
Cuellar, T. L., Herzner, A., Zhang, X., Goyal, Y., Watanabe, C. K., Friedman, B. A., Janakiraman, V., Durinck, S., Stinson, J., Arnott, D. P., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612160 · Cited by 241
Li, Y., Cao, X., Zhu, Y. L., Yang, X., Zhang, K., Xiao, Z., Wang, H., Zhao, J., Zhang, L., Li, G., et al. (2019) · New Phytologist · doi:10.1111/nph.15678 · Cited by 231
Self-citationSelection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing
Liang, G., Zhang, H., Lou, D., & Yu, D. (2016) · Scientific Reports · doi:10.1038/srep21451 · Cited by 240
CRISPR technology is revolutionizing the improvement of tomato and other fruit crops
Wang, T., Zhang, H., & Zhu, H. (2019) · Horticulture Research · doi:10.1038/s41438-019-0159-x · Cited by 236
A CRISPR view of developmentPreprint
Harrison, M. M., Jenkins, B., O’Connor-Giles, K. M., & Wildonger, J. (2014) · Genes & Development · doi:10.1101/gad.248252.114 · Cited by 234
Navigating the Neural Space in Search of the Neural Code
Jazayeri, M., & Afraz, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.019 · Cited by 240
Arsenic Transport in Rice and Biological Solutions to Reduce Arsenic Risk from Rice
Chen, Y., Han, Y.-H., Cao, Y., Zhu, Y., Rathinasabapathi, B., & Ma, L. Q. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00268 · Cited by 227
Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9
El‐Mounadi, K., Morales-Floriano, M. L., & García-Ruíz, H. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00056 · Cited by 231
Realizing the potential of synthetic biology
Church, G. M., Elowitz, M. B., Smolke, C. D., Voigt, C. A., & Weiss, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3767 · Cited by 226
CRISPR‐Cas systems and RNA‐guided interference
Barrangou, R. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1159 · Cited by 232
A scalable strategy for high-throughput GFP tagging of endogenous human proteins
Leonetti, M. D., Sekine, S., Kamiyama, D., Weissman, J. S., & Huang, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606731113 · Cited by 232
Application of CRISPR/Cas9 in plant biology
Liu, X., Wu, S., Xu, J., Sui, C., & Wei, J. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.01.002 · Cited by 235
Non-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Functional Genetic Variants Revealed by Massively Parallel Precise Genome Editing
Sharon, E., Chen, S.-A. A., Khosla, N. M., Smith, J. D., Pritchard, J. K., & Fraser, H. B. (2018) · Cell · doi:10.1016/j.cell.2018.08.057 · Cited by 225
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning
Xiang, X., Corsi, G. I., Anthon, C., Qu, K., Pan, X., Liang, X., Han, P., Dong, Z., Liu, L., Zhong, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23576-0 · Cited by 209
Jensen, K. T., Fløe, L., Petersen, T. S., Huang, J., Xu, F., Bolund, L., Luo, Y., & Lin, L. (2017) · FEBS Letters · doi:10.1002/1873-3468.12707 · Cited by 225
CRMAGE: CRISPR Optimized MAGE Recombineering
Ronda, C., Pedersen, L. E., Sommer, M. O. A., & Nielsen, A. T. (2016) · Scientific Reports · doi:10.1038/srep19452 · Cited by 228
Back to the future: revisiting MAS as a tool for modern plant breeding
Cobb, J. N., Biswas, P. S., & Platten, J. D. (2018) · Theoretical and Applied Genetics · doi:10.1007/s00122-018-3266-4 · Cited by 236
Sugano, S. S., Nishihama, R., Shirakawa, M., Takagi, J., Matsuda, Y., Ishida, S., Shimada, T., Hara‐Nishimura, I., Osakabe, K., & Kohchi, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205117 · Cited by 232
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Lim, C. K. W., Gapinske, M., Brooks, A. K., Woods, W. S., Powell, J. E., C., M. A. Z., Winter, J., Pérez‐Piñera, P., & Gaj, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.005 · Cited by 229
Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease
Fujii, W., Kawasaki, K., Sugiura, K., & Naito, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt772 · Cited by 227
Neurobiology of social behavior abnormalities in autism and Williams syndrome
Barak, B., & Feng, G. (2016) · Nature Neuroscience · doi:10.1038/nn.4276 · Cited by 234
Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage
Stella, S., Alcón, P., & Montoya, G. (2017) · Nature · doi:10.1038/nature22398 · Cited by 244
Sack, L. M., Davoli, T., Li, M. Z., Li, Y., Xu, Q., Naxerova, K., Wooten, E. C., Bernardi, R. J., Martin, T. D., Chen, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.037 · Cited by 225
CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing
Gostimskaya, I. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922080090 · Cited by 224
Rickels, R., Herz, H.-M., Sze, C. C., Cao, K., Morgan, M. A., Collings, C. K., Gause, M., Takahashi, Y.-H., Wang, L., Rendleman, E. J., et al. (2017) · Nature Genetics · doi:10.1038/ng.3965 · Cited by 217
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Genome editing in Ustilago maydis using the CRISPR–Cas system
Schuster, M., Schweizer, G., Reißmann, S., & Kahmann, R. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.09.001 · Cited by 231
Common marmoset as a new model animal for neuroscience research and genome editing technology
Kishi, N., Sato, K., Sasaki, E., & Okano, H. (2014) · Development Growth & Differentiation · doi:10.1111/dgd.12109 · Cited by 224
Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase
Xu, T., Li, Y., Shi, Z. J., Hemme, C. L., Li, Y., Zhu, Y., Nostrand, J. D. V., He, Z., & Zhou, J. Z. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00873-15 · Cited by 231
Riesenberg, S., Groetchen, A., Siddaway, R., Bald, T., Reinhardt, J., Smorra, D., Sirokay, J. D., Renn, M., Phung, B., Aymans, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9755 · Cited by 238
Varshney, G. K., Carrington, B., Pei, W., Bishop, K. S., Chen, Z., Fan, C., Xu, L., Jones, M. S., LaFave, M. C., Ledin, J., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.141 · Cited by 228
Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
Luo, Y., Xu, C., Li, H., Cao, Z., Liu, J., Wang, J., Du, X., Yang, X., Gu, Z., & Wang, J. (2018) · ACS Nano · doi:10.1021/acsnano.7b07874 · Cited by 223
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., Barba‐Ostria, C., & Guamán, L. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00649 · Cited by 232
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Gechijian, L. N., Buckley, D. L., Lawlor, M. A., Reyes, J. M., Paulk, J., Ott, C. J., Winter, G. E., Erb, M. A., Scott, T. G., Xu, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0010-y · Cited by 222
Targeted mutagenesis using CRISPR/Cas system in medaka
Ansai, S., & Kinoshita, M. (2014) · Biology Open · doi:10.1242/bio.20148177 · Cited by 227
Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements
Karvelis, T., Gasiūnas, G., Young, J. K., Bigelyte, G., Šilanskas, A., Cigan, M., & Šikšnys, V. (2015) · Genome biology · doi:10.1186/s13059-015-0818-7 · Cited by 229
Lau, E. S.-W., Zhang, Z., Qin, M., & Ge, W. (2016) · Scientific Reports · doi:10.1038/srep37357 · Cited by 222
Potential of Genome Editing to Improve Aquaculture Breeding and Production
Gratacap, R. L., Wargelius, A., Edvardsen, R. B., & Houston, R. D. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.06.006 · Cited by 227
Generation of a multiplex mutagenesis population via pooled CRISPR ‐Cas9 in soya bean
Bai, M., Juehui, Y., Kuang, H., Gong, P., Li, S., Zhang, Z., Лю, Б., Sun, J., Yang, M., Yang, L., et al. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13239 · Cited by 225
CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
Tang, L., Zeng, Y., Du, H., Gong, M., Peng, J., Zhang, B., Lei, M., Zhao, F., Wang, W., Li, X., et al. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1299-z · Cited by 220
Genetic origins of social networks in rhesus macaques
Brent, L. J. N., Heilbronner, S. R., Horvath, J. E., Gonzalez-Martinez, J., Ruiz-Lambides, A., Robinson, A. G., Skene, J. H. P., & Platt, M. L. (2013) · Scientific Reports · doi:10.1038/srep01042 · Cited by 220
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
Wang, J., & Quake, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410785111 · Cited by 220
Mitochondrial Permeability Uncouples Elevated Autophagy and Lifespan Extension
Zhou, B., Kreuzer, J., Kumsta, C., Wu, L., Kamer, K. J., Cedillo, L., Zhang, Y., Li, S., Kacergis, M. C., Webster, C. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.013 · Cited by 220
Efficient CRISPR-Cas9–mediated genome editing in Plasmodium falciparum
Wagner, J. C., Platt, R. J., Goldfless, S. J., Zhang, F., & Niles, J. C. (2014) · Nature Methods · doi:10.1038/nmeth.3063 · Cited by 227
Self-citationTranscriptional and epigenetic regulation of PPARγ expression during adipogenesis
Lee, J., & Ge, K. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-29 · Cited by 235
Li, C., Guan, X., Du, T., Jin, W., Wu, B., Liu, Y., Wang, P., Hu, B., Griffin, G. E., Shattock, R. J., et al. (2015) · Journal of General Virology · doi:10.1099/vir.0.000139 · Cited by 192
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
McCleland, M. L., Mesh, K., Lorenzana, E. G., Chopra, V. S., Segal, E., Watanabe, C. K., Haley, B., Mayba, O., Yaylaoglu, M., Gnad, F., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83265 · Cited by 224
Jasin, M., & Haber, J. E. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.05.001 · Cited by 229
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
Efficacy of the porcine species in biomedical research
Gutierrez, K., Dicks, N., Glanzner, W. G., Agellon, L. B., & Bordignon, V. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00293 · Cited by 219
Enabling plant synthetic biology through genome engineering
Baltes, N. J., & Voytas, D. F. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.11.008 · Cited by 223
Suravajhala, P., Kogelman, L. J. A., & Kadarmideen, H. N. (2016) · Genetics Selection Evolution · doi:10.1186/s12711-016-0217-x · Cited by 232
Boeke, J. D., Church, G. M., Hessel, A., Kelley, N. J., Arkin, A. P., Cai, Y., Carlson, R. H., Chakravarti, A., Cornish, V. W., Holt, L. J., et al. (2016) · Science · doi:10.1126/science.aaf6850 · Cited by 223
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Donohoue, P. D., Barrangou, R., & May, A. P. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.07.007 · Cited by 227
The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element
Marín-Béjar, O., Mas, A. M., González, J., Martínez, D., Athie, A., Morales, X., Galduroz, M., Raimondi, I., Grossi, E., Guo, S., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1331-y · Cited by 223
Esposito, R., Bosch, N., Lanzós, A., Polidori, T., Pulido-Quetglas, C., & Johnson, R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.019 · Cited by 223
Hanssen, L. L. P., Kassouf, M. T., Oudelaar, A. M., Biggs, D., Preece, C., Downes, D. J., Gosden, M., Sharpe, J. A., Sloane-Stanley, J. A., Hughes, J. R., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3573 · Cited by 219
Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system
Inui, M., Miyado, M., Igarashi, M., Tamano, M., Kubo, A., Yamashita, S., Asahara, H., Fukami, M., & Takada, S. (2014) · Scientific Reports · doi:10.1038/srep05396 · Cited by 230
CRISPR/Cas9 advances engineering of microbial cell factories
Jakočiūnas, T., Jensen, M. K., & Keasling, J. D. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.12.003 · Cited by 225
Loss-of-function genetic tools for animal models: cross-species and cross-platform differences
Housden, B. E., Muhar, M., Gemberling, M. P., Gersbach, C. A., Stainier, D. Y. R., Seydoux, G., Mohr, S. E., Zuber, J. A., & Perrimon, N. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.118 · Cited by 225
Genetic Approaches to Neural Circuits in the Mouse
Josh Huang, Z., & Zeng, H. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170307 · Cited by 200
Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
Singh, R., Kuscu, C., Quinlan, A., Qi, Y., & Adli, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv575 · Cited by 217
Bloom, K., Ely, A., Mussolino, C., Cathomen, T., & Arbuthnot, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.170 · Cited by 217
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
Ma, H., Dang, Y., Wu, Y., Jia, G., Anaya, E., Zhang, J., Abraham, S., Choi, J.-G., Shi, G., Qi, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.049 · Cited by 223
Mao, Y., Zhang, Z., Feng, Z., Wei, P., Zhang, H., Botella, J. R., & Zhu, J. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12468 · Cited by 222
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Zhu, W., Lei, R., Duff, Y. L., Li, J., Guo, F., Wainberg, M. A., & Liang, C. (2015) · Retrovirology · doi:10.1186/s12977-015-0150-z · Cited by 222
Cao, J. P., Wu, L., Zhang, S., Lu, M., Cheung, W. K. C., Cai, W. L., Gale, M., Xu, Q., & Yan, Q. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw660 · Cited by 218
Black, J. B., Adler, A. F., Wang, H., D’Ippolito, A. M., Hutchinson, H., Reddy, T. E., Pitt, G. S., Leong, K. W., & Gersbach, C. A. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.001 · Cited by 223
Liang, C., Li, F., Wang, L., Zhang, Z., Wang, C., He, B., Li, J., Chen, Z., Shaikh, A. B., Liu, J., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.015 · Cited by 217
Self-citationCtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
Charpentier, M., Khedher, A., Ménoret, S., Brion, A., Lamribet, K., Dardillac, E., Boix, C., Perrouault, L., Tesson, L., Geny, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03475-7 · Cited by 229
Transgenic Mouse Models in Cancer Research
Tratar, U. L., Horvat, S., & Čemažar, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00268 · Cited by 231
Nishiyama, J., Mikuni, T., & Yasuda, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.004 · Cited by 215
Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation
Tang, W., Hu, J. H., & Liu, D. R. (2017) · Nature Communications · doi:10.1038/ncomms15939 · Cited by 219
Editing of an Alpha-Kafirin Gene Family Increases, Digestibility and Protein Quality in Sorghum
Li, A., Jia, S., Yobi, A., Ge, Z., Sato, S. J., Zhang, C., Angelovici, R., Clemente, T. E., & Holding, D. R. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.00200 · Cited by 220
CRISPR-Mediated Programmable 3D Genome Positioning and Nuclear Organization
Wang, H., Xu, X., Nguyen, C. M., Liu, Y., Gao, Y., Lin, X., Daley, T., Kipniss, N. H., Russa, M. F. L., & Qi, L. S. (2018) · Cell · doi:10.1016/j.cell.2018.09.013 · Cited by 222
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Tao, J., Bauer, D. E., & Chiarle, R. (2023) · Nature Communications · doi:10.1038/s41467-023-35886-6 · Cited by 232
Site-directed nucleases: a paradigm shift in predictable, knowledge-based plant breeding
Podevin, N., Davies, H. V., Hartung, F., Nogué, F., & Casacuberta, J. M. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.03.004 · Cited by 214
Mikuni, T., Nishiyama, J., Sun, Y., Kamasawa, N., & Yasuda, R. (2016) · Cell · doi:10.1016/j.cell.2016.04.044 · Cited by 218
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
Hou, P., Chen, S., Wang, S., Yu, X., Chen, Y. Z., Jiang, M., Zhuang, K., Ho, W., Hou, W., Huang, J. Y., et al. (2015) · Scientific Reports · doi:10.1038/srep15577 · Cited by 214
CRISPR-Cas9 nuclear dynamics and target recognition in living cells
Ma, H., Tu, L., Naseri, A., Huisman, M., Zhang, S., Grünwald, D., & Pederson, T. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604115 · Cited by 224
Li, S., Ma, Y., Zheng, P., & Zhang, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0744-0 · Cited by 214
Multigene Knockout Utilizing Off-Target Mutations of the CRISPR/Cas9 System in Rice
Endo, M., Mikami, M., & Toki, S. (2014) · Plant and Cell Physiology · doi:10.1093/pcp/pcu154 · Cited by 216
Wang, P., Zhang, L., Xie, Y., Wang, N., Tang, R., Zheng, W., & Jiang, X. (2017) · Advanced Science · doi:10.1002/advs.201700175 · Cited by 215
A Thermostable Cas9 with Increased Lifetime in Human Plasma
Harrington, L. B., Paez-Espino, D., Staahl, B. T., Chen, J. S., Ma, E., Kyrpides, N. C., & Doudna, J. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01408-4 · Cited by 205
Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Shi, J., Kundrat, L., Pishesha, N., Bilate, A. M. B., Theile, C. S., Maruyama, T., Dougan, S. K., Ploegh, H. L., & Lodish, H. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409861111 · Cited by 212
Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 223
Deaminase-mediated multiplex genome editing in Escherichia coli
Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H., & Kondo, A. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0102-6 · Cited by 213
Zhao, H., Li, Y., He, L., Pu, W., Yu, W., Li, Y., Wu, Y., Xu, C., Wei, Y., Ding, Q., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042476 · Cited by 214
Epigenetics and the regulation of stress vulnerability and resilience
Zannas, A. S., & West, A. E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.003 · Cited by 211
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
Jo, A., Ham, S., Lee, G. H., Lee, Y., Kim, S., Lee, Y.-S., Shin, J.-H., & Lee, Y. (2015) · BioMed Research International · doi:10.1155/2015/305716 · Cited by 225
Charpentier, E., & Doudna, J. A. (2013) · Nature · doi:10.1038/495050a · Cited by 229
Liu, H., Zheng, W., Dominguez, A. A., Li, Y., Wang, X., & Qi, L. S. (2015) · Computer applications in the biosciences · doi:10.1093/bioinformatics/btv423 · Cited by 220
Metadata
- Authors
- Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Columbia University (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Rockefeller University (US)
- Corresponding author
- Cong, Le
- Ran, F. Ann
- Zhang, Feng
- ORCID
- Venue
- Science
- Published
- 2013-02-15
- Volume
- 339
- Issue
- 6121
- Pages
- 819-823
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3795411
- OpenAlex
- W2064815984
- Semantic Scholar
- 51bcf2a1577b3dd876fcaa4cdf630f54d261c107
- Cited by
- 15,339
- References
- 32
- Citations by year
- 2026: 614 · 2025: 926 · 2024: 1041 · 2023: 1127 · 2022: 1311 · 2021: 1421 · 2020: 1456 · 2019: 1399 · 2018: 1464 · 2017: 1368 · 2016: 1261 · 2015: 888 · 2014: 732 · 2013: 305
- FWCI
- 476.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01CA133404)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, T32GM007753)
- National Institute of Allergy and Infectious Diseases (DP2AI104556)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided DNA cleavage, nicking enzyme, homology-directed repair, single guide RNA, CRISPR arrays, human cells, mouse cells, mutagenesis
- MeSH terms
- Animals, Base Sequence, DNA, Genetic Engineering, Humans, Molecular Sequence Data, RNA, Streptococcus pyogenes, Mutagenesis, Genome, Microarray Analysis, Mice, DNA Cleavage, Inverted Repeat Sequences, Genetic Loci, Recombinational DNA Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
